Position in GANX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$313,683
+$265,378 QoQ
Shares Held
154,524
+520.6% QoQ
Ownership
0.354%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 49 holders
Holding Since
Dec 2021
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GANX Over Time
Shares Held
Position Value (USD)
Derivatives in GANX
reported options exposure · as of Jun 30, 2026CallValue
$82,621
CallShares
40,700
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names. GANX ranks #291 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
1,425,517 | $406,229,578 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
3,760,028 | $280,046,885 | |
| 3 | INSM |
INSMED Inc
|
2,556,973 | $272,624,460 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
507,233 | $272,358,759 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
510,430 | $253,545,893 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,006,676 | $242,578,715 | |
| 7 | MANE |
Veradermics, Inc
|
1,877,775 | $230,853,658 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,576,261 | $197,343,876 |
All Filings in GANX
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $313,683 | 154,524 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $82,621 | 40,700 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $60,916 | 31,400 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $28,130 | 14,500 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $48,305 | 24,900 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $84,042 | 26,100 | Put | Defined | 2026-02-17 | |
| 2025-12-31 | $165,508 | 51,400 | Call | Defined | 2026-02-17 | |
| 2025-09-30 | $661,197 | 373,558 | Shares | Defined | 2025-11-14 | |
| 2025-09-30 | $18,231 | 10,300 | Call | Defined | 2025-11-14 | |
| 2025-06-30 | $291,268 | 161,816 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $16,617 | 8,700 | Put | Defined | 2025-05-15 | |
| 2025-03-31 | $16,044 | 8,400 | Call | Defined | 2025-05-15 | |
| 2025-03-31 | $36,326 | 19,019 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $25,081 | 11,612 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $22,896 | 10,600 | Put | Defined | 2025-02-14 | |
| 2024-12-31 | $12,312 | 5,700 | Call | Defined | 2025-02-14 | |
| 2024-03-31 | $9,425 | 2,500 | Put | Defined | 2024-05-15 | |
| 2024-03-31 | $15,920 | 4,223 | Shares | Defined | 2024-05-15 | |
| 2024-03-31 | $21,112 | 5,600 | Call | Defined | 2024-05-15 | |
| 2023-12-31 | $213,510 | 65,394 | Shares | Defined | 2024-02-14 | |
| 2023-12-31 | $22,855 | 7,000 | Put | Defined | 2024-02-14 | |
| 2023-12-31 | $4,897 | 1,500 | Call | Defined | 2024-02-14 | |
| 2023-09-30 | $150,473 | 45,876 | Shares | Defined | 2023-11-14 | |
| 2023-09-30 | $13,448 | 4,100 | Put | Defined | 2023-11-14 | |
| 2023-09-30 | $5,576 | 1,700 | Call | Defined | 2023-11-14 | |
| 2023-06-30 | $75,712 | 16,900 | Call | Defined | 2023-08-14 | |
| 2023-06-30 | $162,386 | 36,247 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $61,696 | 12,800 | Call | Defined | 2023-05-15 | |
| 2023-03-31 | $84,093 | 17,447 | Shares | Defined | 2023-05-15 | |
| 2023-03-31 | $482 | 100 | Put | Defined | 2023-05-15 | |
| 2021-12-31 | $70,747 | 13,029 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||